1. Home
  2. QSI vs IRMD Comparison

QSI vs IRMD Comparison

Compare QSI & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QSI
  • IRMD
  • Stock Information
  • Founded
  • QSI 2013
  • IRMD 1992
  • Country
  • QSI United States
  • IRMD United States
  • Employees
  • QSI N/A
  • IRMD N/A
  • Industry
  • QSI Biotechnology: Pharmaceutical Preparations
  • IRMD Medical/Dental Instruments
  • Sector
  • QSI Health Care
  • IRMD Health Care
  • Exchange
  • QSI Nasdaq
  • IRMD Nasdaq
  • Market Cap
  • QSI 219.8M
  • IRMD 756.5M
  • IPO Year
  • QSI N/A
  • IRMD 2014
  • Fundamental
  • Price
  • QSI $1.90
  • IRMD $60.74
  • Analyst Decision
  • QSI Strong Buy
  • IRMD Strong Buy
  • Analyst Count
  • QSI 3
  • IRMD 1
  • Target Price
  • QSI $2.38
  • IRMD $72.00
  • AVG Volume (30 Days)
  • QSI 7.9M
  • IRMD 60.9K
  • Earning Date
  • QSI 08-06-2025
  • IRMD 07-31-2025
  • Dividend Yield
  • QSI N/A
  • IRMD 1.14%
  • EPS Growth
  • QSI N/A
  • IRMD 10.72
  • EPS
  • QSI N/A
  • IRMD 1.55
  • Revenue
  • QSI $3,443,000.00
  • IRMD $75,154,639.00
  • Revenue This Year
  • QSI $77.57
  • IRMD $10.62
  • Revenue Next Year
  • QSI $251.34
  • IRMD $9.69
  • P/E Ratio
  • QSI N/A
  • IRMD $38.58
  • Revenue Growth
  • QSI 167.94
  • IRMD 11.04
  • 52 Week Low
  • QSI $0.61
  • IRMD $42.34
  • 52 Week High
  • QSI $5.77
  • IRMD $63.29
  • Technical
  • Relative Strength Index (RSI)
  • QSI 56.65
  • IRMD 58.74
  • Support Level
  • QSI $1.87
  • IRMD $59.50
  • Resistance Level
  • QSI $2.14
  • IRMD $60.90
  • Average True Range (ATR)
  • QSI 0.14
  • IRMD 1.41
  • MACD
  • QSI 0.01
  • IRMD -0.14
  • Stochastic Oscillator
  • QSI 59.32
  • IRMD 69.91

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: